Clinical Trial Update: Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of thioctic acid (lipoic acid) for symptomatic diabetic polyneuropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy

Drugs mentioned

• thioctic acid (thioctic acid)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Diabetic Polyneuropathy | Phase 3 | Status: COMPLETED